Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
DiStefano, Alfred
NCT01954992: Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer	Recruiting	3	480	US	Glufosfamide, Fluorouracil, 5-FU	Eleison Pharmaceuticals LLC.	Metastatic Pancreatic Adenocarcinoma	06/26	12/26
Carson, Lisa
NCT01954992: Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer	Recruiting	3	480	US	Glufosfamide, Fluorouracil, 5-FU	Eleison Pharmaceuticals LLC.	Metastatic Pancreatic Adenocarcinoma	06/26	12/26